FDA Clearance Tracker · P240045
Optimum Infinite (tisilfocon A) Orthokeratology Lenses II
Last checked: Nov 19, 2026Latest source record: Feb 10, 2026 (this decision)Source: openFDAMethods & limitations
Decided
Feb 10, 2026
Approved
Time to decision
420 days
Received Dec 17, 2024. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA
Device class
Class III
The decision
- FDA number
- P240045
- Device name
- Optimum Infinite (tisilfocon A) Orthokeratology Lenses II
- Applicant
- Contamac, Ltd.
- Applicant location
- Saffron Walden
- Received
- Dec 17, 2024
- Decided
- Feb 10, 2026
- Decision
- Approved
Device type
- Device class
- Class III
- Regulation
- 21 CFR 886.5916
- Specialty
- Ophthalmology
FDA's approval statement
As written in FDA's record.
Approval for Optimum Infinite (tisilfocon A) Ortho-k Lenses, Optimum Infinite (tisilfocon A) Orthokeratology Lenses II.
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code NUU. The earliest in FDA's data is P870024-S043, decided Jun 13, 2002.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
Other decisions for Contamac, Ltd.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K212631 · Decided Mar 17, 2022 · 210 days after receipt
Device type: Lens, Contact (Other Material) - Daily (HQD) · Ophthalmology
K182304 · Decided Nov 23, 2018 · 91 days after receipt
Device type: Lens, Contact (Other Material) - Daily (HQD) · Ophthalmology
- Nutrifill510(k)
K181566 · Decided Oct 22, 2018 · 130 days after receipt
Device type: Products, Contact Lens Care, Rigid Gas Permeable (MRC) · Ophthalmology
5 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.